Katherine E. Brighty

In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial

Thomas D. Gootz, Katherine E. Brighty, Marge R. Anderson et al. · Diagnostic Microbiology and Infectious Disease · 1994 · 41 citations

Antimicrobial Drug Discovery, Biochemistry, Antibiotics +9

Synthesis of (1α,5α,6α)-6-Amino-3-azabicyclo[3.1.0]hexane, a Novel Achiral Diamine

Katherine E. Brighty, Michael J. Castaldi · Synlett · 2000 · 38 citations

Heterocyclic, Modified Curtius Rearrangement, Natural Sciences +9

Anti- <i>Toxoplasma gondii</i> Activities and Structure-Activity Relationships of Novel Fluoroquinolones Related to Trovafloxacin

Anis A. Khan, Fausto G. Araujo, Katherine E. Brighty et al. · Antimicrobial Agents and Chemotherapy · 1999 · 28 citations · Full text

Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.

Deepak Dalvie, Natasha Khosla, Kimberly A. Navetta et al. · Drug Metabolism and Disposition · 1996 · 27 citations

Novel fragmentation of 3-lithio-3,6-dihydro-1,2-oxazines: Synthesis of 2,5-dihydro-2-furanylamines

Manoj C. Desai, Jonathan L. Doty, Linda M. Stephens et al. · Tetrahedron Letters · 1993 · 18 citations

Organic Chemistry, Heterocyclic, Chemistry +1